Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-22

Clinical Trial Update: A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 randomized, open-label, single-dose crossover study evaluating the effect of food on the pharmacokinetics of Dilatrend SR 64 mg capsule in healthy male …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dilatrend SR 64mg Capsule (carvedilol extended-release)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Chronic Stable Angina | Phase 1 | Status: COMPLETED